New pill may help control cholesterol after Weight-Loss drug stop
NCT ID NCT06640972
First seen Jan 06, 2026 · Last updated Apr 29, 2026 · Updated 21 times
Summary
This study tested whether the drug RDX-002 can lower high blood fats (triglycerides) in adults who recently stopped taking popular weight-loss medications like semaglutide or tirzepatide. 68 participants took either RDX-002 or a placebo daily for 12 weeks. Researchers measured blood fat levels after a high-fat meal and tracked body weight and cholesterol changes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHOLESTEROL, ELEVATED are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Nucleus Network
Saint Paul, Minnesota, 55114, United States
Conditions
Explore the condition pages connected to this study.